The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Perioperative allergic reactions, particularly anaphylaxis ... in the administration of epinephrine, a critical treatment for anaphylaxis, with only about 30% of cases receiving it[2].

Anaphylaxis is a rapid and life-threatening allergic reaction that can occur after ... which can lead to inappropriate treatment decisions[4]. Finally, the role of in-vitro testing in diagnosing ...